Johnson Matthey has leading capabilities in developing optimal polymorphs, salt forms, crystal morphology and controlled particles through its PHARMORPHIX® solid form sciences. We offer one of the broadest and most reliable services to ensure effective identification, development and manufacture of your drug candidates and commercial products.

Our solid form services include:

  • Reduced risk of failure during development
  • Meeting regulatory requirements
  • Strengthened intellectual property

  • Effective development of drug candidates
  • Improved bioavailability
  • Enhanced physiochemical properties

  • Unique API intellectual property protection
  • Increased formulation stability
  • Enhanced physiochemical properties

  • Increased solubility and bioavailability
  • Stabilised amorphous forms
  • Controlled particle size distribution

  • Dual source X-ray
  • Assignment of absolute stereochemistry
  • Structure determination from the smallest of crystals

  • Assess the performance of novel crystalline forms
  • Design-appropriate salt and co-crystal screens
  • Investigation of alternative drug delivery routes

  • Optimised enantiomeric excess of chiral products
  • Rapid access to single enantiomers
  • Enrichment of low ee materials

  • Maximised processes yields
  • Reliable crystalline form and morphology
  • Controlled particle size distribution

Get in touch

Send us a message to request a quote or ask our advice. We'd be happy to hear from you.

Chris Worrall


    Send a message

    William McFarlane

    Outside USA

      Send a message

      Read more


      Read about our custom pharma solutions

      Custom pharmaceutical solutions Custom pharmaceutical solutions


      Read our PHARMORPHIX® flyer